🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2029

Annual patent cliff calendar for 2029 — US pharmaceutical patents by expiration date.

Patents
675

Quick answer

675 indexed pharmaceutical patents have expiration dates in 2029. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7501132

    Multiple antigenic peptides immunogenic against Streptococcus pneumonia

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7501448

    Process for preparing telmisartan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7501450

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7501442

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7501415

    Selective inhibitors of ERK protein kinase and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7504109

    Influenza hemagglutinin and neuraminidase variants

    The United States of America as Represented by The Department of Health Services, National Institute of Health · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7504435

    Method for stimulating weight loss and/or for lowering triglycerides in patients

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7504231

    Method of alleviating chronic pain via peripheral inhibition of neurotransmitter synthesis

    The Board of Regents of the University of Oklahoma · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7504504

    Methods of preparing aripiprazole crystalline forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7504096

    Methods for in vitro fertilization

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7504515

    Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate

    Vertex Pharmaceuticals Incorporated · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7504430

    Maleiimide anti-tumor phosphatase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7504246

    Hyaluronan synthase gene and uses thereof

    The Board of Regents of the University of Oklahoma · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7504243

    Methods for the production of biliverdin

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7504101

    Methods for enhancing antigen-specific immune response using antibodies that bind OX-40

    Sisters of Providence in Oregon · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7504233

    Methods for determining the metabolism of sugars and fats in an individual

    The Regents of the University of California · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7504398

    Substituted-4-(pyrrolo pyrimidin-6-yl)benzenesulphonamide derivatives

    Laboratories Almirall, S.A. · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7507407

    Immunoliposomes that optimize internationalization into target cells

    The Regents of the University of California · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7507751

    Biphenyl derivatives

    Theravance, Inc. · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7507826

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7507841

    Cannabinoid receptor modulator

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7507809

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7507861

    Process for the preparation of atomoxetine hydrochloride

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7507716

    Method for treating pain with prolactin antagonists

    The Board of Regents of the University of Texas System · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7507829

    Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7507753

    Biaryl compound and use thereof

    Takeda Chemical Industries Ltd. · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7507740

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7507538

    Human papilloma virus immunoreactive peptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7507556

    Nucleic acids encoding rat hyaluronan receptor for endocytosis

    The Board of Regents of the University of Oklahoma · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7507422

    Urinary tract tissue graft compositions and methods for producing same

    The Board of Regents of the University of Oklahoma · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7511015

    Modified defensins and their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7511124

    Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7510715

    Protozoan derived compositions and methods of use thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7512436

    Method of evaluating metabolism of the eye

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7511174

    Solid and crystalline ibandronic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7510728

    Solid preparations

    Takeda Pharmaceutical Company Limited · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7511137

    Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarboxamide synthetic intermediates

    Rigel Pharmaceuticals, Inc. · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7511038

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7511095

    Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

    Nektar Therapeutics AL, Corporation · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7511032

    Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7511018

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7511094

    Water-soluble polymer alkanals

    Nektar Therapeutics AL, Corporation · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7510710

    Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor

    The Regents of the University of Colorado · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7511053

    Spiroazacyclic compounds as monoamine receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7510726

    Methods and compositions for deterring abuse of opioid containing dosage forms

    Acurx Pharmaceuticals, Inc. · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7514467

    Crystalline solids of carvedilol and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7514558

    Biphenyl derivatives

    Theravance, Inc. · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7514529

    Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2029?

675 published patents in our USPTO index have expiration dates falling in calendar year 2029.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.